Among the seven genes used to construct the signature, SLCO1B1 was expressed at low levels in HCC tissues, whereas the expression of the remaining genes did not differ significantly between HCC and normal tissues. This evidence concerns the gene SLCO1B1 and hepatocellular carcinoma.